LUXLung3-6_2B: LUXLung3-6, figure 2B

LUXLung3-6_2BR Documentation

LUXLung3-6, figure 2B

Description

Kaplan-Meier digitized data from LUXLung3-6, figure 2B (PMID 25589191). A reported sample size of 345,364 for a primary endpoint of PFS in lung cancer.

Usage

`LUXLung3-6_2B`

Format

A data frame of 364 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (afatinib, gemicitabine-cisplatin)

Source

Yang JC-H, Wu Y-L, Schuler M, et al. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials. Lancet Oncol 2015; 16: 141–51.

Examples

summary(`LUXLung3-6_2B`)

kmplot(`LUXLung3-6_2B`)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.